NCT03762863 is a NA clinical trial of Tourniquet application skill retention in Hemorrhage, sponsored by Somerville Office of Emergency Management.

Who is sponsoring NCT03762863?

NCT03762863 is sponsored by Somerville Office of Emergency Management.

What drugs are being tested in NCT03762863?

Interventions in NCT03762863: Tourniquet application skill retention.

What condition does NCT03762863 study?

NCT03762863 studies Hemorrhage.

Is NCT03762863 still recruiting?

NCT03762863 is currently completed. Last updated 25 September 2019.

Last reviewed 2019-09-25 · How we verify

NCT03762863

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Retention of Tourniquet Application Skills Following Participation in a Bleeding Control Course

Completed NA Last updated 25 September 2019

What this trial tests

NA trial testing Tourniquet application skill retention in Hemorrhage in 46 participants. Completed in 30 June 2019.

Timeline

1 November 2018

Primary endpoint
30 June 2019

30 June 2019

Quick facts

Lead sponsor	Somerville Office of Emergency Management
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	46
Start date	1 November 2018
Primary completion	30 June 2019
Estimated completion	30 June 2019
Sites	1 location across United States

Drugs / interventions tested

Tourniquet application skill retention

Conditions studied

Hemorrhage — all drugs for Hemorrhage →

Sponsor

Somerville Office of Emergency Management

Who can join

18 and older, any sex, with Hemorrhage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, observational study of students 6 months after completing a Stop the Bleed course to determine overall ability to effectively use a tourniquet to stop external extremity hemorrhage. Following the release of the Hartford Consensus in October 2015, the American College of Surgeons Committee on Trauma initiated the National Stop the Bleed campaign (2) that among several proactive recommendations was to encourage first responders and the lay public to become trained, equipped and empowered to step forward and intervene in a bleeding emergency. The Stop the Bleed initiative provides baseline education and training in the use of tourniquets to stop extremity hemorrhage when pressure alone does not work. While the program has progressively provided education and training to over 130,000 individuals worldwide there are no recommendations regarding time intervals for refresher training to maintain confidence and competence in the use of tourniquets. The rationale for this study is to ascertain if tourniquet application skills are sufficiently maintained 6 months after participation in a Stop the Bleed course and to provide recommendations for refresher training based on the results.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hemorrhage

Currently open trials in the same condition.

NCT07311343 — Oral Hygiene and Prophylactic Antibiotics to Prevent Intracerebral Hemorrhage Associated Pneumonia · Phase 4 · recruiting
NCT07105904 — Biological and Clinical Relevance of Quantra Viscoelastic Hemostatic Assay in Hemorrhagic Cardiac Surgery · active not recruiting
NCT06979466 — Q Therapeutic System for Chronic Stroke Recovery · NA · recruiting
NCT06664775 — A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate S · Phase 3 · recruiting
NCT06304714 — Effects of Bothrops Spp. Snake Envenomation on Willebrand Factor Activity in Martinique and French Guiana · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03762863 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Somerville Office of Emergency Management
Last refreshed: 25 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03762863.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing